title: Dipeptidylpeptidase IV (DPIV) and alanyl-aminopeptidases (AAPs) as a new target complex for treatment of autoimmune and inflammatory diseases-proof of concept in a mouse model of colitis.
authors.affiliation: IMTM 2 tto-von-Guericke-University Magdeburg, L 39120 Magdeburg, Germany.
authors.forename: Ute
authors.initials: U
authors.lastname: Bank
authors.forename: Janine
authors.initials: J
authors.lastname: Tadje
authors.forename: Martin
authors.initials: M
authors.lastname: Helmuth
authors.forename: Sofia
authors.initials: S
authors.lastname: Stefin
authors.forename: Michael
authors.initials: M
authors.lastname: Täger
authors.forename: Carmen
authors.initials: C
authors.lastname: Wolke
authors.forename: Anke
authors.initials: A
authors.lastname: Wischeropp
authors.forename: Annelore
authors.initials: A
authors.lastname: Ittenson
authors.forename: Dirk
authors.initials: D
authors.lastname: Reinhold
authors.forename: Siegfried
authors.initials: S
authors.lastname: Ansorge
authors.forename: Uwe
authors.initials: U
authors.lastname: Lendeckel
mesh_terms: D000818:Animals; D001327:Autoimmune Diseases / Q000628:therapy*; D018826:CD13 Antigens / Q000378:metabolism*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000502:physiology; D003092:Colitis / Q000139:chemically induced / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D018819:Dipeptidyl Peptidase 4 / Q000378:metabolism*; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D007249:Inflammation / Q000628:therapy*; D008213:Lymphocyte Activation; D051379:Mice; D008807:Mice, Inbred BALB C; D011480:Protease Inhibitors / Q000378:metabolism; D015375:Receptors, Interleukin-2 / Q000276:immunology
chemical_list: D011480:Protease Inhibitors; D015375:Receptors, Interleukin-2; D018826:CD13 Antigens; D018819:Dipeptidyl Peptidase 4